Entacapone | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Entacapone
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Entacapone

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

37 API Suppliers, 19 USDMF, 15 CEP/COS, 6 JDMF, 8 EU WC, 5 KDMF, 12 NDC API, 18 Listed Suppliers, $ API Reference Price

37 API Suppliers
19 USDMF
15 CEP/COS
6 JDMF
8 EU WC
5 KDMF
12 NDC API
18 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

8 Intermediate Suppliers

8 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

162 FDF Dossiers, 35 FDA Orange Book, 100 Europe, 8 Canada, 2 Australia, 4 South Africa, 13 Listed Dossiers

162 FDF Dossiers
35 FDA Orange Book
100 Europe
8 Canada
2 Australia
4 South Africa
13 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG, TABLET;ORAL - 12.5MG;200MG;50MG, TABLET;ORAL - 18.75MG;200MG;75MG, TABLET;ORAL - 25MG;200MG;100MG, TABLET;ORAL - 31.25MG;200MG;125MG, TABLET;ORAL - 37.5MG;200MG;150MG, TABLET;ORAL - 50MG;200MG;200MG

TABLET;ORAL - 200MG
TABLET;ORAL - 12.5MG;200MG;50MG
TABLET;ORAL - 18.75MG;200MG;75MG
TABLET;ORAL - 25MG;200MG;100MG
TABLET;ORAL - 31.25MG;200MG;125MG
TABLET;ORAL - 37.5MG;200MG;150MG
TABLET;ORAL - 50MG;200MG;200MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 2 Rochem International Inc, 17 SPI Pharma, 2 Seqens, 5 DKSH, 1 Pharm-RX Chemical, 8 Faran Shimi Pharmaceutical, 4 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 28 BASF, 1 Bioplus Life Sciences, 11 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 12 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 33 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 9 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 20 Roquette, 14 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

78 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 32 Direct Compression, 32 Disintegrants & Superdisintegrants, 31 Solubilizers, 31 Controlled & Modified Release, 27 Granulation, 25 Thickeners and Stabilizers, 23 Parenteral, 21 Taste Masking, 19 Topical, 18 Co-Processed Excipients, 17 Lubricants & Glidants, 16 Chewable & Orodispersible Aids, 15 Film Formers & Plasticizers, 11 Emulsifying Agents, 8 API Stability Enhancers, 5 Empty Capsules, 5 Coloring Agents, 4 Rheology Modifiers, 4 Vegetarian Capsules, 4 Surfactant & Foaming Agents

78 Fillers, Diluents & Binders
53 Coating Systems & Additives
32 Direct Compression
32 Disintegrants & Superdisintegrants
31 Solubilizers
31 Controlled & Modified Release
27 Granulation
25 Thickeners and Stabilizers
23 Parenteral
21 Taste Masking
19 Topical
18 Co-Processed Excipients
17 Lubricants & Glidants
16 Chewable & Orodispersible Aids
15 Film Formers & Plasticizers
11 Emulsifying Agents
8 API Stability Enhancers
5 Empty Capsules
5 Coloring Agents
4 Rheology Modifiers
4 Vegetarian Capsules
4 Surfactant & Foaming Agents

DIGITAL CONTENT

13 NEWS #PharmaBuzz

13 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 84 Finished Drug Prices, 2 Annual Reports

2 US Medicaid Prescriptions
84 Finished Drug Prices
2 Annual Reports

MARKET PLACE

4 APIs, 1 FDF Dossiers

4 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

2 Health Canada Patents

2 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 2 USP, 3 Others

2 EDQM
2 USP
3 Others

$ API Ref.Price (USD/KG) : 225 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 2Gowling Strathy & Henderson

filter Patent Reset all filters

2 All

01 11334967

02 12342634

filter Product Reset all filters

2 All

01 2Entacapone

filter Dosage Reset all filters

2 All

01 2Tablet

filter Exp Date Reset all filters

2 All

01 12012-03-28

02 12019-09-13

Product Main Page

01

Gowling Strathy & Henderson

Entacapone

BioAsia

Not Confirmed

Gowling Strathy & Henderson

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2012-03-28

Date Granted : 1995-03-28

Brand Name : COMTAN

Patent Number : 1334967

Filing Date : 1987-11-27

Strength per Unit : 200mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2012-03-28

Date Granted : 1995-03-28

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling Strathy & Henderson

Entacapone

BioAsia

Not Confirmed

Gowling Strathy & Henderson

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-09-13

Date Granted : 2008-01-29

Brand Name : COMTAN

Patent Number : 2342634

Filing Date : 1999-09-13

Strength per Unit : 200mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2019-09-13

Date Granted : 2008-01-29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!